• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,415.35 231.99
( 0.31%)
Global Indices
Nasdaq
50,600.73 294.06
(0.58%)
Dow Jones
7,493.73 27.01
(0.36%)
Hang Seng
63,328.42 1,644.28
(2.67%)
Nikkei 225
10,474.02 30.55
(0.29%)
Forex
USD-INR
96.29 -0.42
(-0.43%)
EUR-INR
111.82 -0.44
(-0.39%)
GBP-INR
129.28 -0.40
(-0.31%)
JPY-INR
0.61 0.00
(-0.48%)

EQUITY - MARKET SCREENER

Industry :  
BSE Code
ISIN Demat
Book Value()
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
EPS(TTM)
Face Value()
Div & Yield %
 

Zydus Lifesciences consolidated net profit rises 8.68% in the March 2026 quarter
May 19,2026
Net profit of Zydus Lifesciences rose 8.68% to Rs 1272.50 crore in the quarter ended March 2026 as against Rs 1170.90 crore during the previous quarter ended March 2025. Sales rose 18.19% to Rs 7434.40 crore in the quarter ended March 2026 as against Rs 6290.20 crore during the previous quarter ended March 2025.

For the full year,net profit rose 11.37% to Rs 5040.00 crore in the year ended March 2026 as against Rs 4525.50 crore during the previous year ended March 2025. Sales rose 18.37% to Rs 26719.70 crore in the year ended March 2026 as against Rs 22573.80 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales7434.406290.20 18 26719.7022573.80 18
OPM %34.3633.79 -31.7231.27 -
PBDT2565.602129.50 20 8545.707162.10 19
PBT2057.201891.60 9 7137.706246.30 14
NP1272.501170.90 9 5040.004525.50 11